1-Boc-2-异丙基肼 | 16689-35-3

• 物质功能分类: 有机原料 - 肼或胲的有机衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 1-Boc-2-异丙基肼
• 中文别名: 3-异丙基肼基羧酸叔丁酯；1-BOC-2-异丙基肼
• 英文名称: tert-butyl 2-(isopropyl)hydrazinecarboxylate
• 英文别名: tert-butyl 2-isopropylhydrazine-1-carboxylate；tert-butyl 3-(isopropyl)carbazate；tert-butyl N’-isopropylcarbazate；3-Isopropylcarbazinsaeure-tert-butylester；tert-Butyl 2-isopropylhydrazinecarboxylate；tert-butyl N-(propan-2-ylamino)carbamate
• CAS: 16689-35-3
• 化学式: C₈H₁₈N₂O₂
• 分子量: 174.243
• InChiKey: PUAKAEDMCXRDPR-UHFFFAOYSA-N

物化性质

• 熔点：
  47-51℃
• 沸点：
  80°C/0.6mmHg(lit.)
• 密度：
  0.956
• 溶解度：
  溶于甲醇

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  50.4
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2928000090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温和干燥环境

SDS

tert-Butyl 3-(Isopropyl)carbazate
SAFETY DATA SHEET

---

Section 1. IDENTIFICATION
Product name: tert-Butyl 3-(Isopropyl)carbazate
5.3

---

Section 2. HAZARDS IDENTIFICATION
GHS classification
PHYSICAL HAZARDS Not classified
Not classified
HEALTH HAZARDS
ENVIRONMENTAL HAZARDS Not classified
GHS label elements, including precautionary statements
Pictograms or hazard symbols None
No signal word
Signal word
Hazard statements None
None
Precautionary statements:

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Substance
Components: tert-Butyl 3-(Isopropyl)carbazate
Percent: >98.0%(GC)(T)
CAS Number: 16689-35-3
Synonyms: 3-(Isopropyl)carbazic Acid tert-Butyl Ester , 1-tert-Butoxycarbonyl-2-
isopropylhydrazine , 1-Boc-2-isopropylhydrazine
C8H18N2O2
Chemical Formula:

---

Section 4. FIRST AID MEASURES
Inhalation: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Get medical advice/attention if you feel unwell.
Skin contact: Remove/Take off immediately all contaminated clothing. Rinse skin with
water/shower. If skin irritation or rash occurs: Get medical advice/attention.
Eye contact: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing. If eye irritation persists: Get medical
advice/attention.
Ingestion: Get medical advice/attention if you feel unwell. Rinse mouth.
A rescuer should wear personal protective equipment, such as rubber gloves and air-
Protection of first-aiders:
tight goggles.

---

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing Dry chemical, foam, water spray, carbon dioxide.
media:
Specific hazards arising Take care as it may decompose upon combustion or in high temperatures to
from the chemical: generate poisonous fume.
tert-Butyl 3-(Isopropyl)carbazate

---

Section 5. FIRE-FIGHTING MEASURES
Precautions for firefighters: Fire-extinguishing work is done from the windward and the suitable fire-extinguishing
method according to the surrounding situation is used. Uninvolved persons should
evacuate to a safe place. In case of fire in the surroundings: Remove movable
containers if safe to do so.
Special protective When extinguishing fire, be sure to wear personal protective equipment.
equipment for firefighters:

---

Section 6. ACCIDENTAL RELEASE MEASURES
Use personal protective equipment. Keep people away from and upwind of spill/leak.
Personal precautions,
protective equipment and Entry to non-involved personnel should be controlled around the leakage area by
emergency procedures: roping off, etc.
Environmental precautions: Prevent product from entering drains.
Methods and materials for Sweep dust to collect it into an airtight container, taking care not to disperse it.
containment and cleaning Adhered or collected material should be promptly disposed of, in accordance with
up: appropriate laws and regulations.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Handling is performed in a well ventilated place. Wear suitable protective equipment.
Technical measures:
Prevent dispersion of dust. Wash hands and face thoroughly after handling.
Use a local exhaust if dust or aerosol will be generated.
Advice on safe handling: Avoid contact with skin, eyes and clothing.
Conditions for safe storage, including any
incompatibilities
Storage conditions: Keep container tightly closed. Store in a cool and dark place.
Store away from incompatible materials such as oxidizing agents.
Packaging material: Comply with laws.

---

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Install a closed system or local exhaust as possible so that workers should not be
Engineering controls:
exposed directly. Also install safety shower and eye bath.
Personal protective equipment
Respiratory protection: Dust respirator. Follow local and national regulations.
Hand protection: Protective gloves.
Eye protection: Safety glasses. A face-shield, if the situation requires.
Skin and body protection: Protective clothing. Protective boots, if the situation requires.

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state (20°C): Solid
Form: Crystal- Powder
Colour: White - Almost white
Odour: No data available
pH: No data available
Melting point/freezing point:54°C
80°C/0.1kPa
Boiling point/range:
Flash point: No data available
Flammability or explosive
limits:
No data available
Lower:
Upper: No data available
No data available
Relative density:
Solubility(ies):
No data available
[Water]
[Other solvents]
Methanol
Soluble:
tert-Butyl 3-(Isopropyl)carbazate

---

Section 10. STABILITY AND REACTIVITY
Chemical stability: Stable under proper conditions.
Possibility of hazardous No special reactivity has been reported.
reactions:
Incompatible materials: Oxidizing agents
Hazardous decomposition Carbon monoxide, Carbon dioxide, Nitrogen oxides (NOx)
products:

---

Section 11. TOXICOLOGICAL INFORMATION
No data available
Acute Toxicity:
Skin corrosion/irritation: No data available
No data available
Serious eye
damage/irritation:
Germ cell mutagenicity: No data available
Carcinogenicity:
IARC = No data available
NTP = No data available
No data available
Reproductive toxicity:

---

Section 12. ECOLOGICAL INFORMATION
Ecotoxicity:
No data available
Fish:
Crustacea: No data available
Algae: No data available
Persistence / degradability: No data available
Bioaccumulative No data available
potential(BCF):
Mobility in soil
Log Pow: No data available
No data available
Soil adsorption (Koc):
Henry's Law No data available
constant(PaM3/mol):

---

Section 13. DISPOSAL CONSIDERATIONS
Recycle to process, if possible. Consult your local regional authorities. You may be able to dissolve or mix material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system.
Observe all federal, state and local regulations when disposing of the substance.

---

Section 14. TRANSPORT INFORMATION
Hazards Class: Does not correspond to the classification standard of the United Nations
Not listed
UN-No:

---

Section 15. REGULATORY INFORMATION
Safe management ordinance of dangerous chemical product (State Council announces on January 26, 2002
and revised on February 16,2011): Safe use and production, the storage of a dangerous chemical, transport,
loading and unloading were prescribed.
tert-Butyl 3-(Isopropyl)carbazate

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-Boc-2-异丙基肼 在 甲醇 、 氯化亚砜 、 三乙胺 、 N,N-二异丙基乙胺 、 lithium hydroxide 作用下， 以 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 6.25h， 生成 Boc-AzaVal-Met-Ser-OH
  参考文献：
  名称：

  苯并三唑介导的Aza肽合成：在Aza-Leuenkephalin类似物的途中。

  摘要：

  新颖ñ - （Ñ -Pg-azadipeptidoyl）苯并三唑20A - ë与α氨基酸有效耦合21A - ë，二肽22A - Ç，氨基羟乙酸23A，depsidipeptide 23B，和α羟基β苯基丙酸27屈服，分别，三氮杂肽24a – g，氮杂三肽25a，b，具有氧酰胺键的杂合氮杂三肽26a，具有酯键的杂合氮杂四肽26b杂化的带有酯键的氮杂三肽28。用于合成N -Pg-氮杂三肽33a，b和35a，b的新方案，每个肽在N-末端均包含天然氨基酸，避免了氮杂氨基酸残基的低偶联率并使溶液相成为可能。亮脑啡肽40的氮杂苯丙氨酸类似物的合成。

  DOI：

  10.1021/jo302251e
• 作为产物：
  描述：

  2-甲基-2-丙基2-异亚丙基肼羧酸酯 在 sodium cyanoborohydride 、 溶剂黄146 作用下， 以 四氢呋喃 为溶剂， 生成 1-Boc-2-异丙基肼
  参考文献：
  名称：

  苯并三唑介导的Aza肽合成：在Aza-Leuenkephalin类似物的途中。

  摘要：

  新颖ñ - （Ñ -Pg-azadipeptidoyl）苯并三唑20A - ë与α氨基酸有效耦合21A - ë，二肽22A - Ç，氨基羟乙酸23A，depsidipeptide 23B，和α羟基β苯基丙酸27屈服，分别，三氮杂肽24a – g，氮杂三肽25a，b，具有氧酰胺键的杂合氮杂三肽26a，具有酯键的杂合氮杂四肽26b杂化的带有酯键的氮杂三肽28。用于合成N -Pg-氮杂三肽33a，b和35a，b的新方案，每个肽在N-末端均包含天然氨基酸，避免了氮杂氨基酸残基的低偶联率并使溶液相成为可能。亮脑啡肽40的氮杂苯丙氨酸类似物的合成。

  DOI：

  10.1021/jo302251e

文献信息

• Synthesis of Highly Substituted 1,2-Diazetidin-3-ones, Small-Ring Scaffolds for Drug Discovery
  作者：Marilia S. Santos、Andrew Nortcliffe、William Lewis、Tracey D. Bradshaw、Christopher J. Moody

  DOI：10.1002/chem.201801309

  日期：2018.6.12

  readily accessible, small ring scaffolds that upon functionalization have the potential to produce diverse 3‐dimensional structures for drug discovery. Thus, treatment of diazo hydrazides, obtained from simple hydrazides and malonyl half ester derivatives, followed by diazo transfer, with catalytic amounts of rhodium(II) acetate dimer results in intramolecular carbenoid N−H insertion to give 1,2‐diazetidin‐3‐ones

  1,2-Diazetidin-3-ones是易于获得的小型环型支架，在功能化后可能会产生用于药物发现的多种3维结构。因此，对重氮酰肼的处理（由简单的酰肼和丙二酸半酯衍生物制得），然后重氮转移，并催化量的铑铑（II）二聚体会导致分子内类固醇NH插入，从而生成1,2-二氮杂丁-3-那些。尽管四元环的不稳定性可能会阻碍随后的官能化反应，但通过在N-1处脱保护以及随后形成酰胺或尿素，可以获得许多新的衍生物。X射线晶体学证实了四个四元环的结构。该化合物在乳癌细胞中显示出适度的生长抑制活性。
• Towards a general synthesis of di-aza-amino acids containing peptides
  作者：Faustine Bizet、Nicolo Tonali、Jean-Louis Soulier、Agostino Oliva、Julia Kaffy、Benoit Crousse、Sandrine Ongeri

  DOI：10.1039/c8nj03635g

  日期：——

  difficulty in synthesizing such peptide analogues, as illustrated by the synthesis of tripeptide derivatives containing two consecutive aza-amino acids. Herein, we report some general guidelines regarding the activation and the coupling of alkyl-hydrazides either mutually or with a natural amino acid, taking into account their nucleophilicity and the nature of their side chains.

  虽然已证明在肽中掺入一种氮杂氨基酸有利于诱导结构限制，增加对蛋白水解的抵抗力和改善生物活性，但仅极少数的例子是掺入两种或更多种连续的氮杂氨基酸已经报道。在这项工作中，我们证明了这一事实可能是由于合成此类肽类似物时出乎意料的困难，正如合成含有两个连续氮杂氨基酸的三肽衍生物所说明的那样。在此，我们考虑到烷基酰肼的亲核性和侧链的性质，报告了一些相互关联或与天然氨基酸活化和偶联酰肼的一般指导原则。
• 抗病毒药物及其药物组合物
  申请人：赫斯（西安）生物科技有限公司

  公开号：CN104628771B

  公开（公告）日：2016-05-11

  本发明涉及抗病毒药物及其药物组合物，具体涉及抗人类免疫缺乏病毒(HIV)的药物及其药物组合物，特别是涉及一种可作为逆转录病毒蛋白酶抑制剂的药物，该逆转录病毒蛋白酶抑制剂具有式I所示的化学结构。
• BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE
  申请人：Blaquiere Nicole

  公开号：US20110076291A1

  公开（公告）日：2011-03-31

  Benzoxepin compounds of Formula I, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, wherein: Z 1 is CR 1 or N; Z 2 is CR 2 or N; Z 3 is CR 3 or N; Z 4 is CR 4 or N; and where (i) X 1 is N and X 2 is S, (ii) X 1 is S and X 2 is N, (iii) X 1 is CR 7 and X 2 is S, (iv) X 1 is S and X 2 is CR 7 ; (v) X 1 is NR 8 and X 2 is N, (vi) X 1 is N and X 2 is NR 8 , (vii) X 1 is CR 7 and X 2 is O, (viii) X 1 is O and X 2 is CR 7 , (ix) X 1 is CR 7 and X 2 is C(R 7 ) 2 , (x) X 1 is C(R 7 ) 2 and X 2 is CR 7 ; (xi) X 1 is N and X 2 is O, or (xii) X 1 is O and X 2 is N, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

  Formula I中的苯并氧杂环化合物，包括立体异构体、几何异构体、互变异构体、溶剂化合物、代谢物和其药学上可接受的盐，其中：Z1为CR1或N；Z2为CR2或N；Z3为CR3或N；Z4为CR4或N；其中（i）X1为N且X2为S，（ii）X1为S且X2为N，（iii）X1为CR7且X2为S，（iv）X1为S且X2为CR7；（v）X1为NR8且X2为N，（vi）X1为N且X2为NR8，（vii）X1为CR7且X2为O，（viii）X1为O且X2为CR7，（ix）X1为CR7且X2为C(R7)2，（x）X1为C(R7)2且X2为CR7；（xi）X1为N且X2为O，或（xii）X1为O且X2为N，用于抑制脂质激酶，包括p110α和PI3K的其他同工酶，并用于治疗由脂质激酶介导的癌症等疾病。公开了利用Formula I中的化合物在哺乳动物细胞中进行体外、体内和体内诊断、预防或治疗此类疾病或相关病理状况的方法。
• Synthesis of Macrocycles Derived from Substituted Triazines
  作者：Akop Yepremyan、Arshad Mehmood、Parham Asgari、Benjamin G. Janesko、Eric E. Simanek

  DOI：10.1002/cbic.201800475

  日期：2019.1.18

  Bicycle made from two: Condensation of a small molecule bearing an aldehyde and hydrazine group leads to macrocycles, specifically dimers, in excellent yields. The design rests on a substituted [1,3,5]‐triazine that affords multiple sites for the incorporation of structural diversity.

  由两种材料制成的自行车：带有醛和肼基的小分子缩合会产生大环，特别是二聚体，产率很高。设计基于取代的[1,3,5]-三嗪，该嗪提供了多个结合结构多样性的位点。